Phone
Email
ClinicalTrials.gov URL
Kyoto Drug Discovery and Development Co., Ltd
EA Therapies for Single Patient
Currently, we are not accepting requests.
EA Policies for Single Patient
At this time, KDDD does not offer an expanded access program for KUS121 outside of these ongoing clinical trials.
We understand that patients and physicians may be interested in accessing investigational treatments prior to regulatory approval. However, due to the early stage of development and limited supply of KUS121, we are unable to provide the investigational product through expanded access at this time.